SCHEMBL20042055

SCHEMBL20042055

CCOC(=O)COc1cc([N+](=O)[O-])ccc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.55
KMT2A Q03164 3/20 0.54
MAPT P10636 4/20 0.50
LMNA P02545 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MEN1 O00255 1/20 0.50
RXFP1 Q9HBX9 1/20 0.49
HTT P42858 2/20 0.49
HPGD P15428 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
NTSR1 P30989 1/20 0.48
CYP2C19 P33261 1/20 0.48
NPC1 O15118 1/20 0.48
S1PR4 O95977 1/20 0.48
ITGA4 P13612 1/20 0.48
S1PR1 P21453 1/20 0.48
MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3536740 0.95 ALDH1A1 (0.60) ALDH1A1KMT2AMAPTLMNASMN1; SMN2
SCHEMBL13215153 0.91 POLB (0.57) ALDH1A1KMT2AMAPTLMNASMN1; SMN2
SCHEMBL1106918 0.88 KMT2A (0.56) ALDH1A1KMT2AMAPTLMNASMN1; SMN2
SCHEMBL8865199 0.86 MAPT (0.55) ALDH1A1KMT2AMAPTLMNASMN1; SMN2
SCHEMBL18088093 0.86 MAPT (0.54) ALDH1A1KMT2AMAPTLMNASMN1; SMN2
SCHEMBL3026826 0.85 ALDH1A1 (0.49) ALDH1A1KMT2AMAPTLMNASMN1; SMN2
SCHEMBL27456246 0.85 MAPT (0.50) ALDH1A1KMT2AMAPTLMNASMN1; SMN2
SCHEMBL3535207 0.84 MAPT (0.60) ALDH1A1KMT2AMAPTLMNASMN1; SMN2
SCHEMBL13215131 0.84 POLB (0.52) ALDH1A1KMT2AMAPTLMNASMN1; SMN2
SCHEMBL4861216 0.84 S1PR4 (0.53) ALDH1A1KMT2AMAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180098990-A1 HISTONE DEACETYLASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2018-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180098990-A1 HISTONE DEACETYLASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF HDAC1, HDAC5, HDAC9 ALDH1A1 671/4885KMT2A 31/4885MAPT 3211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.